287 related articles for article (PubMed ID: 26320191)
21. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Schweer K; Kailayangiri S; Campana D; Juergens H; Pule M; Rossig C
Clin Cancer Res; 2009 Aug; 15(15):4857-66. PubMed ID: 19638467
[TBL] [Abstract][Full Text] [Related]
22. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
23. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
24. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
25. Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria.
Newman KC; Korbel DS; Hafalla JC; Riley EM
PLoS Pathog; 2006 Dec; 2(12):e118. PubMed ID: 17154717
[TBL] [Abstract][Full Text] [Related]
26. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
Treichel RS; Olken S
Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
[TBL] [Abstract][Full Text] [Related]
27. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R
Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771
[TBL] [Abstract][Full Text] [Related]
28. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.
Vremec D; O'Keeffe M; Hochrein H; Fuchsberger M; Caminschi I; Lahoud M; Shortman K
Blood; 2007 Feb; 109(3):1165-73. PubMed ID: 17038535
[TBL] [Abstract][Full Text] [Related]
29. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.
Ogasawara K; Yoshinaga SK; Lanier LL
J Immunol; 2002 Oct; 169(7):3676-85. PubMed ID: 12244160
[TBL] [Abstract][Full Text] [Related]
30. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
Liu C; Lou Y; Lizée G; Qin H; Liu S; Rabinovich B; Kim GJ; Wang YH; Ye Y; Sikora AG; Overwijk WW; Liu YJ; Wang G; Hwu P
J Clin Invest; 2008 Mar; 118(3):1165-75. PubMed ID: 18259609
[TBL] [Abstract][Full Text] [Related]
31. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).
Hanabuchi S; Watanabe N; Wang YH; Wang YH; Ito T; Shaw J; Cao W; Qin FX; Liu YJ
Blood; 2006 May; 107(9):3617-23. PubMed ID: 16397134
[TBL] [Abstract][Full Text] [Related]
32. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.
Xun C; Brown SA; Jennings CD; Henslee-Downey PJ; Thompson JS
Transplantation; 1993 Aug; 56(2):409-17. PubMed ID: 8356598
[TBL] [Abstract][Full Text] [Related]
33. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation.
North J; Bakhsh I; Marden C; Pittman H; Addison E; Navarrete C; Anderson R; Lowdell MW
J Immunol; 2007 Jan; 178(1):85-94. PubMed ID: 17182543
[TBL] [Abstract][Full Text] [Related]
34. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q.
Omatsu Y; Iyoda T; Kimura Y; Maki A; Ishimori M; Toyama-Sorimachi N; Inaba K
J Immunol; 2005 Jun; 174(11):6657-62. PubMed ID: 15905504
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
Peragine N; Torelli GF; Mariglia P; Pauselli S; Vitale A; Guarini A; Foà R
Cancer Immunol Immunother; 2015 Feb; 64(2):201-11. PubMed ID: 25341808
[TBL] [Abstract][Full Text] [Related]
36. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta.
Sato K; Hida S; Takayanagi H; Yokochi T; Kayagaki N; Takeda K; Yagita H; Okumura K; Tanaka N; Taniguchi T; Ogasawara K
Eur J Immunol; 2001 Nov; 31(11):3138-46. PubMed ID: 11745330
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
Mavilio D; Lombardo G; Kinter A; Fogli M; La Sala A; Ortolano S; Farschi A; Follmann D; Gregg R; Kovacs C; Marcenaro E; Pende D; Moretta A; Fauci AS
J Exp Med; 2006 Oct; 203(10):2339-50. PubMed ID: 17000867
[TBL] [Abstract][Full Text] [Related]
38. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.
Esplugues E; Vega-Ramos J; Cartoixà D; Vazquez BN; Salaet I; Engel P; Lauzurica P
Blood; 2005 Jun; 105(11):4399-406. PubMed ID: 15692061
[TBL] [Abstract][Full Text] [Related]
39. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy.
Hayakawa Y; Screpanti V; Yagita H; Grandien A; Ljunggren HG; Smyth MJ; Chambers BJ
J Immunol; 2004 Jan; 172(1):123-9. PubMed ID: 14688317
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of ADAM17 in cord blood stem cell-derived CD16
Valipour B; Mohammadi SM; Abedelahi A; Charoudeh HN
Hum Immunol; 2024 May; 85(3):110769. PubMed ID: 38429146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
